Auro Laboratories Ltd

Auro Laboratories Ltd

₹ 231 -10.00%
12 Nov - close price
About

Incorporated in 1989, Auro Laboratories Limited is into the manufacturing of Active Pharmaceutical Ingredients (APIs), specializing in Diabetes therapy. The company also also undertakes Toll/Custom Manufacturing for API's and Intermediates on contract basis.
Key API Products of Auro Labs are:[1]
- Metformin Hydrochloride
- Chlorzoxzone
- Chlorphenamine Maleate

Key Points

Product Portfolio:[1]
a) Active Pharmaceutical Ingredients:
Anti-Diabetics, Anti-Histamines, Muscle Relaxants, Diuretics, Anti Fungal, Anti Ulcer, Anti Fungal, Anti Ulcer, Iodine Supplement, Iron Supplement, Anti Malaria, Analgesics, Antacids, Anti Inflammatory, Specialty Chemicals, etc.
b) Intermediates: [2]
Few Intermediates which are used in APIs are Glibenclamide, Ketoconazol, Sildenafil Citrate, and Citalopram

  • Market Cap 144 Cr.
  • Current Price 231
  • High / Low 307 / 112
  • Stock P/E 23.4
  • Book Value 69.6
  • Dividend Yield 0.00 %
  • ROCE 20.4 %
  • ROE 20.5 %
  • Face Value 10.0

Pros

  • Company's working capital requirements have reduced from 116 days to 89.4 days

Cons

  • Stock is trading at 3.32 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 2.76% over past five years.
  • Company has a low return on equity of 12.9% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
10.32 12.14 17.88 11.19 12.56 15.62 13.52 10.18 13.41 17.98 12.06 5.72 3.10
9.20 10.93 16.97 10.62 11.54 15.17 11.17 9.02 10.38 13.90 9.65 4.39 2.38
Operating Profit 1.12 1.21 0.91 0.57 1.02 0.45 2.35 1.16 3.03 4.08 2.41 1.33 0.72
OPM % 10.85% 9.97% 5.09% 5.09% 8.12% 2.88% 17.38% 11.39% 22.60% 22.69% 19.98% 23.25% 23.23%
0.29 0.02 0.28 0.05 -0.16 0.43 0.62 0.36 0.32 0.42 0.40 0.20 0.31
Interest 0.15 0.16 0.40 0.26 0.32 0.10 0.13 0.27 0.35 0.44 -0.32 0.25 0.28
Depreciation 0.26 0.26 0.24 0.25 0.25 0.27 0.30 0.27 0.27 0.27 0.28 0.27 0.27
Profit before tax 1.00 0.81 0.55 0.11 0.29 0.51 2.54 0.98 2.73 3.79 2.85 1.01 0.48
Tax % 29.00% 24.69% 16.36% 27.27% 27.59% 27.45% 29.53% 27.55% 27.84% 27.70% 18.60% 24.75% 25.00%
0.71 0.61 0.46 0.08 0.21 0.37 1.78 0.71 1.97 2.73 2.32 0.75 0.36
EPS in Rs 1.14 0.98 0.74 0.13 0.34 0.59 2.86 1.14 3.16 4.38 3.72 1.20 0.58
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
44.28 33.74 32.65 27.91 35.47 40.79 46.82 43.79 54.25 50.87 52.89 53.64 38.86
41.01 30.95 29.71 25.11 31.03 34.43 39.83 37.51 43.01 46.24 48.50 42.96 30.32
Operating Profit 3.27 2.79 2.94 2.80 4.44 6.36 6.99 6.28 11.24 4.63 4.39 10.68 8.54
OPM % 7.38% 8.27% 9.00% 10.03% 12.52% 15.59% 14.93% 14.34% 20.72% 9.10% 8.30% 19.91% 21.98%
0.06 0.06 0.24 0.42 0.53 0.51 0.96 0.97 0.76 1.09 0.94 1.50 1.33
Interest 1.85 1.53 1.66 1.66 1.18 1.21 0.87 0.58 0.46 0.83 0.81 0.74 0.65
Depreciation 0.72 0.74 0.72 0.68 0.86 0.93 1.01 1.02 1.04 1.02 1.07 1.09 1.09
Profit before tax 0.76 0.58 0.80 0.88 2.93 4.73 6.07 5.65 10.50 3.87 3.45 10.35 8.13
Tax % 0.00% 0.00% 0.00% 0.00% 72.01% 25.16% 27.51% 27.96% 31.62% 26.61% 28.99% 24.64%
0.77 0.58 0.80 0.88 0.82 3.53 4.40 4.05 7.18 2.84 2.44 7.79 6.16
EPS in Rs 1.24 0.93 1.28 1.41 1.32 5.66 7.06 6.50 11.52 4.56 3.91 12.50 9.88
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 5%
5 Years: 3%
3 Years: 0%
TTM: -26%
Compounded Profit Growth
10 Years: 30%
5 Years: 12%
3 Years: 3%
TTM: 28%
Stock Price CAGR
10 Years: 41%
5 Years: 34%
3 Years: 26%
1 Year: 77%
Return on Equity
10 Years: 18%
5 Years: 17%
3 Years: 13%
Last Year: 20%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23
Reserves 0.09 0.67 1.47 2.35 3.18 6.75 11.18 15.27 22.35 25.29 27.97 35.73 37.13
16.75 14.80 16.41 12.62 4.95 9.20 8.09 3.16 3.16 13.78 6.41 26.25 34.22
6.75 5.14 4.67 4.49 12.45 8.23 7.97 7.68 10.15 9.66 15.38 17.52 6.45
Total Liabilities 29.82 26.84 28.78 25.69 26.81 30.41 33.47 32.34 41.89 54.96 55.99 85.73 84.03
10.68 10.51 9.80 9.13 13.00 13.02 14.59 14.24 13.56 13.61 12.62 22.15 21.61
CWIP 0.00 0.06 0.82 3.33 0.23 1.07 0.12 0.12 0.13 3.68 7.67 32.68 39.86
Investments 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05
19.09 16.22 18.11 13.18 13.53 16.27 18.71 17.93 28.15 37.62 35.65 30.85 22.51
Total Assets 29.82 26.84 28.78 25.69 26.81 30.41 33.47 32.34 41.89 54.96 55.99 85.73 84.03

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1.46 4.48 -0.78 7.88 6.49 6.05 6.87 9.30 12.82 -6.59 3.28 18.81
-0.52 -0.56 -0.73 -2.44 -2.20 -3.04 -3.19 -2.21 -3.51 -5.34 -5.08 -38.67
-0.79 -2.99 0.53 -5.34 -3.81 -1.77 -1.83 -5.52 -0.46 9.79 -8.18 19.09
Net Cash Flow 0.15 0.93 -0.98 0.09 0.47 1.24 1.86 1.58 8.85 -2.14 -9.98 -0.77

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 66.52 46.95 94.80 66.04 79.13 74.90 66.26 48.18 49.12 97.65 85.57 91.11
Inventory Days 72.37 115.33 89.37 86.72 21.65 22.00 42.98 60.54 32.60 47.32 120.27 113.24
Days Payable 64.73 62.97 56.12 72.03 80.26 78.26 66.19 70.67 73.51 54.12 117.41 85.34
Cash Conversion Cycle 74.17 99.30 128.05 80.73 20.52 18.64 43.05 38.04 8.20 90.86 88.44 119.01
Working Capital Days 89.27 94.12 138.51 97.17 67.20 64.70 63.46 51.09 33.84 123.56 134.64 89.41
ROCE % 11.71% 9.43% 10.74% 11.21% 23.06% 32.51% 29.11% 24.84% 38.87% 12.20% 9.92% 20.38%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
51.99% 51.99% 52.09% 52.09% 52.09% 52.09% 52.09% 52.09% 52.09% 52.15% 52.15% 52.15%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
48.00% 48.00% 47.91% 47.91% 47.92% 47.90% 47.90% 47.92% 47.90% 47.85% 47.84% 47.84%
No. of Shareholders 10,18911,34011,36211,18311,13510,90610,50110,2729,9059,4419,3359,266

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents